Published in Ir Med J on September 30, 1993
Progression model for pancreatic cancer. Clin Cancer Res (2000) 4.60
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res (1997) 4.54
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (1999) 2.59
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50
Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res (2000) 2.40
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res (1998) 1.71
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
Molecular pathology of pancreatic cancer. Cancer J (2001) 1.56
Familial pancreatic cancer. Cancer J (2001) 1.51
Familial pancreatic cancer. Ann Oncol (1999) 1.33
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res (2001) 1.22
Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther (2005) 1.18
Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg (1998) 1.17
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br J Cancer (2003) 1.16
Pathology of incipient pancreatic cancer. Ann Oncol (1999) 1.10
Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut (2005) 1.09
Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol (2000) 1.00
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut (1996) 0.95
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. Br J Cancer (2011) 0.94
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol (2001) 0.89
Molecular genetics and related developments in pancreatic cancer. Curr Opin Gastroenterol (1999) 0.89
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. Am J Pathol (2001) 0.86
A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene (2006) 0.85
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. Gastroenterology (2000) 0.84
Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol (2010) 0.83
Calcium and phosphate balance in dialysis patients. Kidney Int Suppl (1993) 0.82
Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol (1997) 0.82
Genetics of the FANCA gene in familial pancreatic cancer. J Med Genet (2004) 0.82
Elevated levels of circulating soluble adhesion molecules in patients with nonrheumatic aortic stenosis. Am J Cardiol (1997) 0.81
Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients? Perit Dial Int (1993) 0.79
BRCA2 and predisposition to pancreatic and other cancers. Expert Rev Mol Med (2001) 0.79
Carcinoma of the ampulla of Vater: a tumour with a poor prognosis? Eur J Gastroenterol Hepatol (1996) 0.78
Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients. Transplant Proc (1999) 0.78
Separate risk factors for the development of transplant glomerulopathy vs chronic tubulointerstitial rejection. Transplant Proc (1997) 0.77
Use and benefits of a Web site for pancreatic cancer. JAMA (1998) 0.77
Cholesterol inhibition, cancer, and coronary heart disease. Lancet (1992) 0.75
Interferon first in chronic hepatitis C. BMJ (1993) 0.75
Theophylline and sleep-disordered breathing in heart failure. N Engl J Med (1997) 0.75
Impact of pre-existing left ventricular dysfunction on kidney transplantation outcomes: implications for patient selection. Transplant Proc (2011) 0.75
Recent developments in the medical management of peptic ulcer disease. Ir Med J (1994) 0.75
Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols. Transplant Proc (2005) 0.75
Nephrotic syndrome, renal vein thrombosis, and folate deficiency in a young man: is there a relationship to homocysteine metabolism? Nephrol Dial Transplant (1995) 0.75
Idiopathic constipation. Ir Med J (1996) 0.75
Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine. Transplant Proc (1999) 0.75
Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients. Transplant Proc (1997) 0.75
Non-accidental injury. Radiogr Today (1989) 0.75
Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Ann Oncol (1999) 0.75
Transplantation in peritoneal dialysis and hemodialysis. Kidney Int Suppl (1993) 0.75